EGCG re-expresses several transcriptionally silenced genes via inhibiting DNMT1 activity, decreases growth, induces apoptosis in renal cell carcinoma by the re-expression of tissue factor pathway inhibitor-2 (TFPI-2), and decreases promoter hypermethylation. This evidence concerns the gene TFPI2 and hereditary clear cell renal cell carcinoma.